SAN FRANCISCO, Dec. 20, 2017 — Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive officer of Invitae, will present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at 2:00 p.m. Pacific at The Westin St. Francis in San Francisco.
The live webcast of the presentation may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company's website.
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics in clinical areas across all stages of life, Invitae is aggregating the world's genetic tests into a single service with better quality, faster turnaround time, and lower prices. The company provides a variety of diagnostic tests with clinical utility in preimplantation and carrier screening for inherited disorders, miscarriage analysis, pediatric and developmental disorders, neurological disorders, cardiovascular disorders, metabolic disorders, and hereditary cancers. For more information, visit our website at invitae.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/invitae-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300573711.html
SOURCE Invitae Corporation
Latest posts by Sarah Thompson (see all)
- Personalized Lifestyle Medicine Institute to Host 2018 Thought Leaders Consortium in Tucson - February 20, 2018
- JetBlue Appoints Steve Forte, Vice President, JetBlue University - February 20, 2018
- RagingWire Launches 100% Renewable / 100% Available Power Solution at Its Northern California Data Centers - February 20, 2018